Good clinical practice (GCP) quality risk management supports effective delivery of clinical development programs and ultimately the delivery of treatments to patients. Our white paper benchmarks the maturity for top-10 pharma companies in their use of GCP quality analytics to drive scientific decisions. Through detailed desk research and industry interviews, we shine a light on three questions:
- What is the framework used to analyze the maturity of pharma organizations and how do these pharma companies fare on the maturity scale?
- What are some of the frontier practices in organizations with high GCP analytics maturity?
- How can companies leapfrog their GCP analytics maturity?
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
